| Name | Title | Contact Details |
|---|
Hawaii Farm Bureau Federation is a Honolulu, HI-based company in the Business Services sector.
Rubix, an L1 green #blockchain 🌱 protocol for peer-to-peer data transfer & transactions. https://t.co/p9RVzPrqWy https://t.co/BVeE4jkhkC https://t.co/2cFNrrYTS7
Fletcher Home Improvements is a Trenton, NJ-based company in the Business Services sector.
Dane Street is a national IME and Peer Review organization headquartered in Boston, MA. We are focused exclusively on providing credible, objective and timely examinations and reviews. We process over 175,000 referrals annually for leading national and regional Workers Compensation, Disability, Auto and Group Health Carriers, Third Party Administrators, Managed Care Organizations, Employers, Pharmacy Benefit Managers and Medicare Set-Aside providers to provide customized IME and Peer Review programs which assist their RNs and Adjusters in reaching the appropriate medical determination as part of the claims management process. At Dane Street, we are committed to “finishing the job.” We realize your referrals to us require careful and timely attention—on each case—from referral initiation to delivery back to your team. Our entire team is committed to consistently meeting your highest expectations around turn-around time, quality, responsiveness, and ease of doing business.
Vansen Pharma Inc. is a specialty pharmaceutical company focused on broad therapeutic areas that are anticipated to grow and present an opportunity for major expansion. Vansen will expand its commercial presence by adding complimentary products through in-licensing, co-promotion and acquisitions, resulting in a comprehensive product portfolio. With its US based sales force, Vansen can better serve the increasing healthcare needs of patients and enhance growth. Vansen's current product portfolio of anti-infectives, including Factive®, Spectracef® and Cefditoren Pivoxil®, provides a strong and stable revenue base from which to grow and expand our company. Our experienced management team is aggressively pursuing acquisitions of accretive specialty products, including legacy drugs and cash flow positive healthcare companies. We look forward to executing our growth strategy and creating lasting shareholder value for our investors.